GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Curachem Co Ltd (XKRX:456190) » Definitions » Buildings And Improvements

Curachem Co (XKRX:456190) Buildings And Improvements : ₩0.00 Mil (As of . 20)


View and export this data going back to 2023. Start your Free Trial

What is Curachem Co Buildings And Improvements?


Curachem Co Buildings And Improvements Historical Data

The historical data trend for Curachem Co's Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curachem Co Buildings And Improvements Chart

Curachem Co Annual Data
Trend
Buildings And Improvements

Curachem Co Semi-Annual Data
Buildings And Improvements

Curachem Co Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction.  Broker and architect fees, permits, etc. can be covered within this category.  Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized.  Improvements are commonly recorded at acquisition cost.  Building improvement examples include roofing, remodeling, replacements, etc.


Curachem Co Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
207, Osongsaengmyeong 1-ro, Osong-eup, Heungdeok-gu, Chungcheongbuk-do, Cheongju-si, KOR, 28161
Curachem Co Ltd is a manufacturing lab of radiolabeled compounds. Its main products include radiolabeled compounds used for in vivo absorption, distribution, metabolism, and excretion (ADME) studies, Phase I mass balance and micro-dosing (phase 0 and enhanced Phase I) research, and various works in a production facility, such as manufacturing, quality control, and quality assurance.

Curachem Co Headlines

No Headlines